|
| 4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- Basic information |
Product Name: | 4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- | Synonyms: | 4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)-;Emavusertib(CA-4948);Emavusertib;rheumatoid,inflammation,CD135,inhibit,IL-1R associated kinase,CA4948,lymphoma,Interleukin-1 receptor associated kinase,Fms like tyrosine kinase 3,FLT3,arthritis,Inhibitor,CA 4948,Cluster of differentiation antigen 135,Myd88,IL-1R,IRAK,Toll,CA-4948;(R)-N-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-4-yl)oxazole-4-carboxamide | CAS: | 1801344-14-8 | MF: | C24H25N7O5 | MW: | 491.5 | EINECS: | | Product Categories: | | Mol File: | 1801344-14-8.mol | |
| 4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- Chemical Properties |
density | 1.457±0.06 g/cm3(Predicted) | storage temp. | -20°C | solubility | DMSO: soluble | form | A solid | pka | 11.24±0.43(Predicted) |
| 4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- Usage And Synthesis |
| 4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- Preparation Products And Raw materials |
|